Echo Therapeutics, Inc. Asset Impairment Charges
Echo Therapeutics, Inc. reported Asset Impairment Charges of $0 for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2016-11-16
- Echo Therapeutics, Inc. asset impairment charges for the quarter ending 2016-09-30 was $0.00.
- Echo Therapeutics, Inc. asset impairment charges for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Echo Therapeutics, Inc. asset impairment charges for the quarter ending 2015-12-31 was $0.00.
- Echo Therapeutics, Inc. asset impairment charges for the quarter ending 2015-09-30 was $0.00.
- Echo Therapeutics, Inc. asset impairment charges for fiscal 2015 was $9.63M.
- Echo Therapeutics, Inc. asset impairment charges for fiscal 2014 was $0.00.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-16 | $0.00 derived: sum of 2 quarters · filed 2016-11-16 | $0.00 10-Q · filed 2016-11-16 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-11-16 | $9.63M derived: sum of 3 quarters · filed 2016-11-16 | $9.63M 10-K · filed 2016-03-30 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-16 | $9.63M derived: sum of 2 quarters · filed 2016-11-16 | $9.63M 10-Q · filed 2016-11-16 | |
| 2015-06-30 | $9.63M 10-Q · filed 2016-08-12 | $9.63M 10-Q · filed 2016-08-12 | ||
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |